These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6165189)
61. The use of stable isotopes to prove the saturable first-pass effect of methoxsalen. Schmid J; Prox A; Zipp H; Koss FW Biomed Mass Spectrom; 1980 Nov; 7(11-12):560-4. PubMed ID: 7225539 [TBL] [Abstract][Full Text] [Related]
62. Rapid, sensitive gas chromatographic analysis of 8-methoxypsoralen in human plasma. Schmid J; Koss FW J Chromatogr; 1978 Nov; 146(3):498-502. PubMed ID: 721926 [No Abstract] [Full Text] [Related]
63. [Quantitative determination of 5-methoxypsoralen in plasma by liquid chromatography and spectrofluorometric detection]. Prognon P; Simon G; Mahuzier G J Chromatogr; 1983 Jan; 272(1):193-9. PubMed ID: 6841540 [No Abstract] [Full Text] [Related]
64. [Comparative study of plasma levels of 8-methoxypsoralen. Effect of the pharmaceutical formulation and of diet]. Monfrecola G; Martellotta D; De Stefano S; Bruno G; Santoianni P G Ital Dermatol Venereol; 1986; 121(5):327-30. PubMed ID: 3793142 [No Abstract] [Full Text] [Related]
65. Fluorescence detection of an 8-methoxypsoralen metabolite in human interstitial fluid. Blais J; Dubertret L; Gaboriau F; Vigny P Photochem Photobiol; 1982 Mar; 35(3):423-6. PubMed ID: 7063557 [No Abstract] [Full Text] [Related]
66. The photochemical interaction between the triplet state of 8-methoxypsoralen and the melanin precursor L-3,4 dihydroxyphenylalanine. Craw M; Chedekel MR; Truscott TG; Land EJ Photochem Photobiol; 1984 Feb; 39(2):155-9. PubMed ID: 6709722 [No Abstract] [Full Text] [Related]
68. Clinical pharmacokinetics of methoxsalen and other psoralens. de Wolff FA; Thomas TV Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141 [TBL] [Abstract][Full Text] [Related]
69. A pharmacokinetic comparison in dogs of seven brands of 8-MOP and five new formulations. Van Boven M; Roelandts R; De Greef H; Kinget R; Adriaens P; Daenens P Photodermatol; 1985 Feb; 2(1):27-31. PubMed ID: 3982992 [TBL] [Abstract][Full Text] [Related]
70. Bioavailability study of two different 8-methoxypsoralen (8-MOP) preparations in patients receiving PUVA therapy. Nørgaard M; Hueg B; Staberg B Photodermatol; 1985 Aug; 2(4):252-6. PubMed ID: 3903679 [TBL] [Abstract][Full Text] [Related]
71. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen. Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489 [TBL] [Abstract][Full Text] [Related]
72. Plasma levels of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinin tablets. Thune P Acta Derm Venereol; 1978; 58(2):149-51. PubMed ID: 76395 [TBL] [Abstract][Full Text] [Related]